Basic Information
| LncRNA/CircRNA Name | circZMIZ1 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | qPCR |
| Sample | prostate cancer plasma and cell liens |
| Expression Pattern | up-regulated |
| Function Description | we demonstrated that the expression of circZMIZ1 was higher in plasma of human prostate cancer than the paired benign prostatic hyperplasia (BPH) patients' plasma. Moreover, in cultured prostate cancer cells, knockdown of circZMIZ1 inhibited cell proliferation and caused cell cycle arrest at G1. |
| Pubmed ID | 31686520 |
| Year | 2019 |
| Title | Upregulated circZMIZ1 Promotes the Proliferation of Prostate Cancer Cells and Is a Valuable Marker in Plasma |
External Links
| Links for circZMIZ1 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |